Does TAMOXIFEN Cause Malignant neoplasm progression? 1,499 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,499 reports of Malignant neoplasm progression have been filed in association with TAMOXIFEN (Tamoxifen Citrate). This represents 16.5% of all adverse event reports for TAMOXIFEN.
1,499
Reports of Malignant neoplasm progression with TAMOXIFEN
16.5%
of all TAMOXIFEN reports
89
Deaths
104
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TAMOXIFEN?
Of the 1,499 reports, 89 (5.9%) resulted in death, 104 (6.9%) required hospitalization, and 19 (1.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAMOXIFEN. However, 1,499 reports have been filed with the FAERS database.
What Other Side Effects Does TAMOXIFEN Cause?
Metastases to bone (894)
Fatigue (729)
Nausea (611)
Metastases to liver (595)
Breast cancer (584)
Disease progression (571)
Breast cancer metastatic (515)
Diarrhoea (512)
Arthralgia (497)
Drug ineffective (493)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TAMOXIFEN Alternatives Have Lower Malignant neoplasm progression Risk?
TAMOXIFEN vs TAMSULOSIN
TAMOXIFEN vs TAPENTADOL
TAMOXIFEN vs TAPINAROF
TAMOXIFEN vs TARCEVA
TAMOXIFEN vs TARLATAMAB